NCT Number,Study Title,Study URL,Acronym,Study Status,Brief Summary,Study Results,Conditions,Interventions,Primary Outcome Measures,Secondary Outcome Measures,Other Outcome Measures,Sponsor,Collaborators,Sex,Age,Phases,Enrollment,Funder Type,Study Type,Study Design,Other IDs,Start Date,Primary Completion Date,Completion Date,First Posted,Results First Posted,Last Update Posted,Locations,Study Documents
NCT00690833,Efficacy of Desonide (Desonatetm) Gel 0.05% in Younger and Older Subjects With Atopic Dermatitis,https://clinicaltrials.gov/study/NCT00690833,,COMPLETED,The purpose of this research study is to better understand how this study drug works when people use it to treat atopic dermatitis. Desonate has been approved by the US Food and Drug Administration (FDA) for atopic dermatitis.,YES,Atopic Dermatitis,DRUG: topical desonide hydrogel 0.05%,"Investigator Global Assessment at Week 4, The Investigator global assessment at Week 4 is based on an overall scale of 0-4 with 0 being clear and 4 being very severe, Week 4",,,Wake Forest University,,ALL,"CHILD, ADULT, OLDER_ADULT",PHASE4,41,OTHER,INTERVENTIONAL,Allocation: NA|Intervention Model: SINGLE_GROUP|Masking: NONE|Primary Purpose: TREATMENT,IRB00002928|32426,2007-08,2007-12,2009-11,2008-06-05,2017-02-08,2018-09-10,"Wake Forest University Health Sciences Dermatology, Winston-Salem, North Carolina, 27157, United States",
